BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22996917)

  • 1. Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium.
    Pruitt FL; He Y; Franco OE; Jiang M; Cates JM; Hayward SW
    Prostate; 2013 Apr; 73(5):476-88. PubMed ID: 22996917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells.
    Shigemura K; Huang WC; Li X; Zhau HE; Zhu G; Gotoh A; Fujisawa M; Xie J; Marshall FF; Chung LW
    Prostate; 2011 Dec; 71(16):1711-22. PubMed ID: 21520153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
    Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression.
    He Y; Franco OE; Jiang M; Williams K; Love HD; Coleman IM; Nelson PS; Hayward SW
    Cancer Res; 2007 Sep; 67(17):8188-97. PubMed ID: 17804732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.
    Barclay WW; Woodruff RD; Hall MC; Cramer SD
    Endocrinology; 2005 Jan; 146(1):13-8. PubMed ID: 15471963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative control of epithelial cell proliferation by prostatic stroma.
    Kooistra A; König JJ; Romijn JC; Schröder FH
    Anticancer Res; 1991; 11(4):1495-500. PubMed ID: 1720936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts.
    Zhao H; Peehl DM
    Prostate; 2009 Jun; 69(9):991-1000. PubMed ID: 19267366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
    Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
    Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocytic promotion of prostate cellular proliferation.
    McDowell KL; Begley LA; Mor-Vaknin N; Markovitz DM; Macoska JA
    Prostate; 2010 Mar; 70(4):377-89. PubMed ID: 19866464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid-activated insulin-like growth factor binding protein protease activity of cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma.
    Nunn SE; Peehl DM; Cohen P
    J Cell Physiol; 1997 May; 171(2):196-204. PubMed ID: 9130467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.
    Zenzmaier C; Untergasser G; Hermann M; Dirnhofer S; Sampson N; Berger P
    Prostate; 2008 Apr; 68(5):540-7. PubMed ID: 18247400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.
    Nguyen EV; Pereira BA; Lawrence MG; Ma X; Rebello RJ; Chan H; Niranjan B; Wu Y; Ellem S; Guan X; Wu J; Skhinas JN; Cox TR; Risbridger GP; Taylor RA; Lister NL; Daly RJ
    Mol Cell Proteomics; 2019 Jul; 18(7):1410-1427. PubMed ID: 31061140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer.
    Zenzmaier C; Sampson N; Plas E; Berger P
    Prostate; 2013 Sep; 73(13):1441-52. PubMed ID: 23765731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor.
    Planz B; Aretz HT; Wang Q; Tabatabaei S; Kirley SD; Lin CW; McDougal WS
    Prostate; 1999 Dec; 41(4):233-42. PubMed ID: 10544296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms.
    Bavik C; Coleman I; Dean JP; Knudsen B; Plymate S; Nelson PS
    Cancer Res; 2006 Jan; 66(2):794-802. PubMed ID: 16424011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study.
    Kooistra A; Romijn JC; Schröder FH
    Urol Res; 1997; 25 Suppl 2():S97-105. PubMed ID: 9144894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytically inactive human cathepsin D triggers fibroblast invasive growth.
    Laurent-Matha V; Maruani-Herrmann S; Prébois C; Beaujouin M; Glondu M; Noël A; Alvarez-Gonzalez ML; Blacher S; Coopman P; Baghdiguian S; Gilles C; Loncarek J; Freiss G; Vignon F; Liaudet-Coopman E
    J Cell Biol; 2005 Jan; 168(3):489-99. PubMed ID: 15668295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment.
    Vickman RE; Broman MM; Lanman NA; Franco OE; Sudyanti PAG; Ni Y; Ji Y; Helfand BT; Petkewicz J; Paterakos MC; Crawford SE; Ratliff TL; Hayward SW
    Prostate; 2020 Feb; 80(2):173-185. PubMed ID: 31763714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
    Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
    Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.